Given that we and another group have shown that cholesterol acts as an endogenous ligand of ERRα and increases its transcriptional activity and cellular growth [30,31], it was of interest to elucidate the metabolic pathways by which the cholesterol-ERRα axis may mediate its pathogenic effect in breast cancer cells. Here, ESRRA is linked to breast cancer.